Industry Research Reports

Home > Reports > Chemical & Material > Global and United States Milbemycin Oxime API Market Report & Forecast 2023-2029

Global and United States Milbemycin Oxime API Market Report & Forecast 2023-2029

Industry: Chemical & Material

Published: 2023-07-31

Pages: 71 Pages

Report ld: 1616574

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

Market Analysis and Insights: Global and United States Milbemycin Oxime API Market

This report focuses on global and United States Milbemycin Oxime API market, also covers the segmentation data of other regions in regional level and county level.

The global Milbemycin Oxime API revenue was US$ 183.7 million in 2022 and is forecast to a readjusted size of US$ 304 million by 2029 with a CAGR of 6.4% during the forecast period (2023-2029).

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

Global Milbemycin Oxime API Scope and Market Size
Milbemycin Oxime API market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Milbemycin Oxime API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For United States market, this report focuses on the Milbemycin Oxime API market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.

By Company
Livzon Pharmaceutical Group Inc
Zhejiang Hisun Pharmaceutical Co., Ltd
Hubei Honch Pharmaceutical Co.,Ltd
JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD

Segment by Type
98% Purity
Purity Greater than 98%

Segment by Application
Dog
Cat
Other

By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction
Chapter 1: Introduces Milbemycin Oxime API definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Milbemycin Oxime API companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Milbemycin Oxime API in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8: China by type, by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Milbemycin Oxime API sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: Research findings and conclusion

Table of Contents

 1 Study Coverage
    1.1 Milbemycin Oxime API Product Introduction
    1.2 Global Milbemycin Oxime API Outlook 2018 VS 2022 VS 2029
        1.2.1 Global Milbemycin Oxime API Sales in US$ Million for the Year 2018-2029
        1.2.2 Global Milbemycin Oxime API Sales in Volume for the Year 2018-2029
    1.3 United States Milbemycin Oxime API Outlook 2018 VS 2022 VS 2029
        1.3.1 United States Milbemycin Oxime API Sales in US$ Million for the Year 2018-2029
        1.3.2 United States Milbemycin Oxime API Sales in Volume for the Year 2018-2029
    1.4 Milbemycin Oxime API Market Size, United States VS Global, 2018 VS 2022 VS 2029
        1.4.1 The Market Share of United States Milbemycin Oxime API in Global, 2018 VS 2022 VS 2029
        1.4.2 The Growth Rate of Milbemycin Oxime API Market Size, United States VS Global, 2018 VS 2022 VS 2029
    1.5 Milbemycin Oxime API Market Dynamics
        1.5.1 Milbemycin Oxime API Industry Trends
        1.5.2 Milbemycin Oxime API Market Drivers
        1.5.3 Milbemycin Oxime API Market Challenges
        1.5.4 Milbemycin Oxime API Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
    1.8 Years Considered

 2 Milbemycin Oxime API by Type
    2.1 Milbemycin Oxime API Market Segment by Type
        2.1.1 98% Purity
        2.1.2 Purity Greater than 98%
    2.2 Global Milbemycin Oxime API Market Size by Type
        2.2.1 Global Milbemycin Oxime API Sales in Value, by Type (2018, 2022 & 2029)
        2.2.2 Global Milbemycin Oxime API Sales in Volume, by Type (2018, 2022 & 2029)
        2.2.3 Global Milbemycin Oxime API Average Selling Price (ASP) by Type (2018, 2022 & 2029)
    2.3 United States Milbemycin Oxime API Market Size by Type
        2.3.1 United States Milbemycin Oxime API Sales in Value, by Type (2018, 2022 & 2029)
        2.3.2 United States Milbemycin Oxime API Sales in Volume, by Type (2018, 2022 & 2029)
        2.3.3 United States Milbemycin Oxime API Average Selling Price (ASP) by Type (2018, 2022 & 2029)

 3 Milbemycin Oxime API by Application
    3.1 Milbemycin Oxime API Market Segment by Application
        3.1.1 Dog
        3.1.2 Cat
        3.1.3 Other
    3.2 Global Milbemycin Oxime API Market Size by Application
        3.2.1 Global Milbemycin Oxime API Sales in Value, by Application (2018, 2022 & 2029)
        3.2.2 Global Milbemycin Oxime API Sales in Volume, by Application (2018, 2022 & 2029)
        3.3.3 Global Milbemycin Oxime API Average Selling Price (ASP) by Application (2018, 2022 & 2029)
    3.3 United States Milbemycin Oxime API Market Size by Application
        3.3.1 United States Milbemycin Oxime API Sales in Value, by Application (2018, 2022 & 2029)
        3.3.2 United States Milbemycin Oxime API Sales in Volume, by Application (2018, 2022 & 2029)
        3.3.3 United States Milbemycin Oxime API Average Selling Price (ASP) by Application (2018, 2022 & 2029)

 4 Global Milbemycin Oxime API Competitor Landscape by Company
    4.1 Global Milbemycin Oxime API Market Size by Company
        4.1.1 Global Key Manufacturers of Milbemycin Oxime API, Ranked by Revenue (2022)
        4.1.2 Global Milbemycin Oxime API Revenue by Manufacturer (2018-2023)
        4.1.3 Global Milbemycin Oxime API Sales by Manufacturer (2018-2023)
        4.1.4 Global Milbemycin Oxime API Price by Manufacturer (2018-2023)
    4.2 Global Milbemycin Oxime API Concentration Ratio (CR)
        4.2.1 Milbemycin Oxime API Market Concentration Ratio (CR)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Milbemycin Oxime API in 2022
        4.2.3 Global Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Key Manufacturers of Milbemycin Oxime API, Manufacturing Base Distribution and Headquarters
    4.4 Global Key Manufacturers of Milbemycin Oxime API, Product Offered and Application
    4.5 Global Key Manufacturers of Milbemycin Oxime API, Date of Enter into This Industry
    4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.7 United States Milbemycin Oxime API Market Size by Company
        4.7.1 Key Players of Milbemycin Oxime API in United States, Ranked by Revenue (2022)
        4.7.2 United States Milbemycin Oxime API Revenue by Players (2018-2023)
        4.7.3 United States Milbemycin Oxime API Sales by Players (2018-2023)

 5 Global Milbemycin Oxime API Market Size by Region
    5.1 Global Milbemycin Oxime API Market Size by Region: 2018 VS 2022 VS 2029
    5.2 Global Milbemycin Oxime API Market Size in Volume by Region (2018-2029)
        5.2.1 Global Milbemycin Oxime API Sales in Volume by Region: 2018-2023
        5.2.2 Global Milbemycin Oxime API Sales in Volume Forecast by Region (2024-2029)
    5.3 Global Milbemycin Oxime API Market Size in Value by Region (2018-2029)
        5.3.1 Global Milbemycin Oxime API Sales in Value by Region: 2018-2023
        5.3.2 Global Milbemycin Oxime API Sales in Value by Region: 2024-2029

 6 Americas
    6.1 Americas Milbemycin Oxime API Market Size YoY Growth 2018-2029
    6.2 Americas Milbemycin Oxime API Sales in Volume, by Type (2018, 2022 & 2029)
    6.3 Americas Milbemycin Oxime API Sales in Volume, by Application (2018, 2022 & 2029)
    6.4 Americas Milbemycin Oxime API Market Facts & Figures by Country (2018, 2022 & 2029)
        6.4.1 Americas Milbemycin Oxime API Sales in Value by Country (2018, 2022 & 2029)
        6.4.2 Americas Milbemycin Oxime API Sales in Volume by Country (2018, 2022 & 2029)
        6.4.3 United States
        6.4.4 Canada
        6.4.5 Mexico
        6.4.6 Brazil

 7 EMEA
    7.1 EMEA Milbemycin Oxime API Market Size YoY Growth 2018-2029
    7.2 EMEA Milbemycin Oxime API Sales in Volume, by Type (2018, 2022 & 2029)
    7.3 EMEA Milbemycin Oxime API Sales in Volume, by Application (2018, 2022 & 2029)
    7.4 EMEA Milbemycin Oxime API Market Facts & Figures by Country (2018, 2022 & 2029)
        7.4.1 EMEA Milbemycin Oxime API Sales in Value by Country (2018, 2022 & 2029)
        7.4.2 EMEA Milbemycin Oxime API Sales in Volume by Country (2018, 2022 & 2029)
        7.4.3 Europe
        7.4.4 Middle East
        7.4.5 Africa

 8 China
    8.1 China Milbemycin Oxime API Market Size YoY Growth 2018-2029
    8.2 China Milbemycin Oxime API Sales in Volume, by Type (2018, 2022 & 2029)
    8.3 China Milbemycin Oxime API Sales in Volume, by Application (2018, 2022 & 2029)

 9 APAC
    9.1 APAC Milbemycin Oxime API Market Size YoY Growth 2018-2029
    9.2 APAC Milbemycin Oxime API Sales in Volume, by Type (2018, 2022 & 2029)
    9.3 APAC Milbemycin Oxime API Sales in Volume, by Application (2018, 2022 & 2029)
    9.4 APAC Milbemycin Oxime API Market Facts & Figures by Region (2018, 2022 & 2029)
        9.4.1 APAC Milbemycin Oxime API Sales in Value by Region (2018, 2022 & 2029)
        9.4.2 APAC Milbemycin Oxime API Sales in Volume by Region (2018, 2022 & 2029)
        9.4.3 Japan
        9.4.4 South Korea
        9.4.5 China Taiwan
        9.4.6 Southeast Asia
        9.4.7 India

 10 Company Profiles
    10.1 Livzon Pharmaceutical Group Inc
        10.1.1 Livzon Pharmaceutical Group Inc Company Information
        10.1.2 Livzon Pharmaceutical Group Inc Description and Business Overview
        10.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Products Offered
        10.1.5 Livzon Pharmaceutical Group Inc Recent Development
    10.2 Zhejiang Hisun Pharmaceutical Co., Ltd
        10.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
        10.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Description and Business Overview
        10.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Products Offered
        10.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Development
    10.3 Hubei Honch Pharmaceutical Co.,Ltd
        10.3.1 Hubei Honch Pharmaceutical Co.,Ltd Company Information
        10.3.2 Hubei Honch Pharmaceutical Co.,Ltd Description and Business Overview
        10.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Products Offered
        10.3.5 Hubei Honch Pharmaceutical Co.,Ltd Recent Development
    10.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
        10.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Information
        10.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Description and Business Overview
        10.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Products Offered
        10.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Development

 11 Industry Chain and Sales Channels Analysis
    11.1 Milbemycin Oxime API Industry Chain Analysis
    11.2 Milbemycin Oxime API Key Raw Materials
        11.2.1 Key Raw Materials
        11.2.2 Raw Materials Key Suppliers
    11.3 Milbemycin Oxime API Production Mode & Process
    11.4 Milbemycin Oxime API Sales and Marketing
        11.4.1 Milbemycin Oxime API Sales Channels
        11.4.2 Milbemycin Oxime API Distributors
    11.5 Milbemycin Oxime API Customers

 12 Research Findings and Conclusion

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Milbemycin Oxime API CAGR in Value, United States VS Global, 2018 VS 2022 VS 2029
    Table 2. Milbemycin Oxime API Market Trends
    Table 3. Milbemycin Oxime API Market Drivers
    Table 4. Milbemycin Oxime API Market Challenges
    Table 5. Milbemycin Oxime API Market Restraints
    Table 6. Global Milbemycin Oxime API Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. United States Milbemycin Oxime API Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Milbemycin Oxime API Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. United States Milbemycin Oxime API Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Milbemycin Oxime API, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Milbemycin Oxime API Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Milbemycin Oxime API Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Milbemycin Oxime API Sales by Manufacturer, (KG), 2018-2023
    Table 14. Global Milbemycin Oxime API Sales Share by Manufacturer, 2018-2023
    Table 15. Global Milbemycin Oxime API Price by Manufacturer (2018-2023) & (US$/KG)
    Table 16. Global Milbemycin Oxime API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Milbemycin Oxime API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Milbemycin Oxime API as of 2022)
    Table 18. Global Key Manufacturers of Milbemycin Oxime API, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Milbemycin Oxime API, Product Offered and Application
    Table 20. Global Key Manufacturers of Milbemycin Oxime API, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Milbemycin Oxime API in United States, Ranked by Revenue (2022) & (US$ million)
    Table 23. United States Milbemycin Oxime API Revenue by Players, (US$ Million), (2018-2023)
    Table 24. United States Milbemycin Oxime API Revenue Share by Players, (2018-2023)
    Table 25. United States Milbemycin Oxime API Sales by Players, (KG), (2018-2023)
    Table 26. United States Milbemycin Oxime API Sales Share by Players, (2018-2023)
    Table 27. Global Milbemycin Oxime API Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Milbemycin Oxime API Sales in Volume by Region (2018-2023) & (KG)
    Table 29. Global Milbemycin Oxime API Sales in Volume Forecast by Region (2024-2029) & (KG)
    Table 30. Global Milbemycin Oxime API Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Milbemycin Oxime API Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Milbemycin Oxime API Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Milbemycin Oxime API Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Milbemycin Oxime API Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Milbemycin Oxime API Sales in Volume by Country (2018-2023) & (KG)
    Table 36. Americas Milbemycin Oxime API Sales in Volume by Country (2024-2029) & (KG)
    Table 37. EMEA Milbemycin Oxime API Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Milbemycin Oxime API Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Milbemycin Oxime API Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Milbemycin Oxime API Sales in Volume by Country (2018-2023) & (KG)
    Table 41. EMEA Milbemycin Oxime API Sales in Volume by Country (2024-2029) & (KG)
    Table 42. APAC Milbemycin Oxime API Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Milbemycin Oxime API Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Milbemycin Oxime API Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Milbemycin Oxime API Sales in Volume by Country (2018-2023) & (KG)
    Table 46. APAC Milbemycin Oxime API Sales in Volume by Country (2024-2029) & (KG)
    Table 47. Livzon Pharmaceutical Group Inc Company Information
    Table 48. Livzon Pharmaceutical Group Inc Description and Business Overview
    Table 49. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 50. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product
    Table 51. Livzon Pharmaceutical Group Inc Recent Development
    Table 52. Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
    Table 53. Zhejiang Hisun Pharmaceutical Co., Ltd Description and Business Overview
    Table 54. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 55. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product
    Table 56. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Development
    Table 57. Hubei Honch Pharmaceutical Co.,Ltd Company Information
    Table 58. Hubei Honch Pharmaceutical Co.,Ltd Description and Business Overview
    Table 59. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 60. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product
    Table 61. Hubei Honch Pharmaceutical Co.,Ltd Recent Development
    Table 62. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Information
    Table 63. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Description and Business Overview
    Table 64. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 65. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product
    Table 66. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Milbemycin Oxime API Customers List
    Table 70. Milbemycin Oxime API Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Milbemycin Oxime API Product Picture
    Figure 2. Global Milbemycin Oxime API Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Milbemycin Oxime API Market Size 2018-2029 (US$ Million)
    Figure 4. Global Milbemycin Oxime API Sales 2018-2029 (KG)
    Figure 5. United States Milbemycin Oxime API Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. United States Milbemycin Oxime API Market Size 2018-2029 (US$ Million)
    Figure 7. United States Milbemycin Oxime API Sales 2018-2029 (KG)
    Figure 8. United States Milbemycin Oxime API Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. United States Milbemycin Oxime API Market Share in Global, in Volume (KG) 2018-2029
    Figure 10. Milbemycin Oxime API Report Years Considered
    Figure 11. Product Picture of 98% Purity
    Figure 12. Product Picture of Purity Greater than 98%
    Figure 13. Global Milbemycin Oxime API Market Share by Type in 2022 & 2029
    Figure 14. Global Milbemycin Oxime API Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 15. Global Milbemycin Oxime API Sales Market Share in Value by Type (2018-2029)
    Figure 16. Global Milbemycin Oxime API Sales by Type (2018-2029) & (KG)
    Figure 17. Global Milbemycin Oxime API Sales Market Share in Volume by Type (2018-2029)
    Figure 18. Global Milbemycin Oxime API Price by Type (2018-2029) & (US$/KG)
    Figure 19. United States Milbemycin Oxime API Market Share by Type in 2022 & 2029
    Figure 20. United States Milbemycin Oxime API Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 21. United States Milbemycin Oxime API Sales Market Share in Value by Type (2018-2029)
    Figure 22. United States Milbemycin Oxime API Sales by Type (2018-2029) & (KG)
    Figure 23. United States Milbemycin Oxime API Sales Market Share in Volume by Type (2018-2029)
    Figure 24. United States Milbemycin Oxime API Price by Type (2018-2029) & (US$/KG)
    Figure 25. Product Picture of Dog
    Figure 26. Product Picture of Cat
    Figure 27. Product Picture of Other
    Figure 28. Global Milbemycin Oxime API Market Share by Application in 2022 & 2029
    Figure 29. Global Milbemycin Oxime API Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 30. Global Milbemycin Oxime API Sales Market Share in Value by Application (2018-2029)
    Figure 31. Global Milbemycin Oxime API Sales by Application (2018-2029) & (KG)
    Figure 32. Global Milbemycin Oxime API Sales Market Share in Volume by Application (2018-2029)
    Figure 33. Global Milbemycin Oxime API Price by Application (2018-2029) & (US$/KG)
    Figure 34. United States Milbemycin Oxime API Market Share by Application in 2022 & 2029
    Figure 35. United States Milbemycin Oxime API Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 36. United States Milbemycin Oxime API Sales Market Share in Value by Application (2018-2029)
    Figure 37. United States Milbemycin Oxime API Sales by Application (2018-2029) & (KG)
    Figure 38. United States Milbemycin Oxime API Sales Market Share in Volume by Application (2018-2029)
    Figure 39. United States Milbemycin Oxime API Price by Application (2018-2029) & (US$/KG)
    Figure 40. Americas Milbemycin Oxime API Sales in Volume Growth Rate 2018-2029 (KG)
    Figure 41. Americas Milbemycin Oxime API Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 42. Americas Milbemycin Oxime API Sales by Type (2018-2029) & (KG)
    Figure 43. Americas Milbemycin Oxime API Sales Market Share in Volume by Type (2018-2029)
    Figure 44. Americas Milbemycin Oxime API Sales by Application (2018-2029) & (KG)
    Figure 45. Americas Milbemycin Oxime API Sales Market Share in Volume by Application (2018-2029)
    Figure 46. United States Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Canada Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Mexico Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. EMEA Milbemycin Oxime API Sales in Volume Growth Rate 2018-2029 (KG)
    Figure 51. EMEA Milbemycin Oxime API Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 52. EMEA Milbemycin Oxime API Sales by Type (2018-2029) & (KG)
    Figure 53. EMEA Milbemycin Oxime API Sales Market Share in Volume by Type (2018-2029)
    Figure 54. EMEA Milbemycin Oxime API Sales by Application (2018-2029) & (KG)
    Figure 55. EMEA Milbemycin Oxime API Sales Market Share in Volume by Application (2018-2029)
    Figure 56. Europe Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Middle East Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Africa Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. China Milbemycin Oxime API Sales in Volume Growth Rate 2018-2029 (KG)
    Figure 60. China Milbemycin Oxime API Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 61. China Milbemycin Oxime API Sales by Type (2018-2029) & (KG)
    Figure 62. China Milbemycin Oxime API Sales Market Share in Volume by Type (2018-2029)
    Figure 63. China Milbemycin Oxime API Sales by Application (2018-2029) & (KG)
    Figure 64. China Milbemycin Oxime API Sales Market Share in Volume by Application (2018-2029)
    Figure 65. APAC Milbemycin Oxime API Sales in Volume Growth Rate 2018-2029 (KG)
    Figure 66. APAC Milbemycin Oxime API Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 67. APAC Milbemycin Oxime API Sales by Type (2018-2029) & (KG)
    Figure 68. APAC Milbemycin Oxime API Sales Market Share in Volume by Type (2018-2029)
    Figure 69. APAC Milbemycin Oxime API Sales by Application (2018-2029) & (KG)
    Figure 70. APAC Milbemycin Oxime API Sales Market Share in Volume by Application (2018-2029)
    Figure 71. Japan Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 72. South Korea Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. China Taiwan Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. Southeast Asia Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. India Milbemycin Oxime API Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Milbemycin Oxime API Value Chain
    Figure 77. Milbemycin Oxime API Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed

Description

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

Market Analysis and Insights: Global and United States Milbemycin Oxime API Market

This report focuses on global and United States Milbemycin Oxime API market, also covers the segmentation data of other regions in regional level and county level.

The global Milbemycin Oxime API revenue was US$ 183.7 million in 2022 and is forecast to a readjusted size of US$ 304 million by 2029 with a CAGR of 6.4% during the forecast period (2023-2029).

By Company
Livzon Pharmaceutical Group Inc
Zhejiang Hisun Pharmaceutical Co., Ltd
Hubei Honch Pharmaceutical Co.,Ltd
JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD

Segment by Type
98% Purity
Purity Greater than 98%

Segment by Application
Dog
Cat
Other

By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Industry: Chemical & Material

Published: 2023-07-31

Pages: 71 Pages

Report ld: 1616574

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 4350.00

Multi Users License

USD 6525.00

Corporate Users License